Research Comparison
Cagrilintide (AM833) vs Retatrutide
A side-by-side research comparison of Cagrilintide (AM833) and Retatrutide drawn from DRPSHP' peptide database records.
Cagrilintide (AM833)
Native human amylin is a poor research tool: the 37-residue hormone that pancreatic beta cells release alongside insulin aggregates readily and does not last long in circulation. Analogues are engineered to get round both problems, and Cagrilintide is one of them — a synthetic amylin analogue carrying a fatty-acid side chain that binds albumin in blood, which lengthened its half-life in pharmacokinetic studies. It is described as acting at amylin receptors and at the calcitonin receptor. Animal work was followed by human clinical trials in metabolic research, both of the compound alone and alongside a GLP-1 receptor agonist. Set against the literature on amylin itself, the published pharmacology of this analogue is recent and narrow.
Retatrutide
Retatrutide (development code LY3437943) is a synthetic peptide designed to stimulate three hormone receptors at once: those for GIP, GLP-1 and glucagon. GIP and GLP-1 are incretins, hormones the gut releases in response to food, while glucagon comes from the alpha cells of the pancreas, and all three receptors belong to one family. Earlier synthetic agonists of this family acted on one or two of the receptors; retatrutide's distinguishing feature is engaging all three. Its pharmacology has been described in cell assays and animal studies, and it has been examined in human clinical trials in metabolic disease.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.